Peptide

Tesamorelin

also known as Egrifta

Growth hormone-releasing peptide for visceral fat reduction.

Nightly subcutaneous tesamorelin, a GHRH analog that stimulates the body's own growth hormone release to reduce visceral abdominal fat and improve body composition, prescribed with baseline and follow-up IGF-1 and metabolic labs.

Provider-reviewedLicensed in your stateCold-chain shipping
Start consultation

about 4 minutes. You'll only pay if you're approved and choose a plan.

Plans

You'll pick a plan after the intake. Your card is only charged if a clinician approves your request.

Starting dose
1 mg
Low / Starter
$249/month

No separate care-team fee.

Low / Starter monthly tier for Tesamorelin, prescribed only when clinically appropriate.

  • Monthly supply
  • Cancel anytime from your account
1.5 mg
Standard
$299/month

No separate care-team fee.

Standard monthly tier for Tesamorelin, prescribed only when clinically appropriate.

  • Monthly supply
  • Cancel anytime from your account

Available after clinician review — treatment starts on the starting dose.

2 mg
High / Intensive
$349/month

No separate care-team fee.

High / Intensive monthly tier for Tesamorelin, prescribed only when clinically appropriate.

  • Monthly supply
  • Cancel anytime from your account

Available after clinician review — treatment starts on the starting dose.